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We hypothesised that cleaning the internal limiting membrane (ILM) with a flexible nitinol loop 
following diabetic vitrectomy without peeling may reduce the common occurrence of postoperative 
epiretinal membrane (ERM) formation.   
Methods 
Consecutive patients undergoing vitrectomy for proliferative diabetic retinopathy by one surgeon 
from 2015-2019 were studied and divided into two cohorts: the control group underwent standard 
surgery; the ILM-Clean group underwent additional cleaning of the macular retina using a flexible 
nitinol loop post-vitrectomy. Masked comparison of ERM on optical coherence tomography was 
performed at 3 months and visual acuity (VA) was measured until 12 months postoperatively.  
Results 
Baseline demographics, clinical features and protein levels were similar between cohorts. The ILM-
Clean group (n=56) had fewer clinically significant ERM compared to the control group (n=50) 
(4%vs.20%;p=0.01) and a significantly lower proportion of the ILM-Clean group required revision 
surgery (2%vs.14%;p=0.02). VA in the ILM-Clean group was significantly better than the control group 
at 3 months (0.35vs.0.50logMAR;p=0.02) but not at 12 months (0.34vs.0.43logMAR;p=0.17).  
Conclusion 
ILM cleaning with a flexible nitinol loop following diabetic vitrectomy resulted in significant reduction 
in ERM formation and reduced necessity for revision surgery. There was significant improvement in 












   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   






























Epiretinal membrane (ERM) formation is a well-known association of proliferative diabetic 
retinopathy (PDR) and can lead to a variety of tractional consequences with reduced vision. Its 
occurrence relates to a range of effects secondary to raised glucose levels including changes in 
vitreous structure, an abnormal adhesion between the vitreous cortex and internal limiting 
membrane (ILM) of the retina, and a pro-proliferative cytokine mix in the vitreous cavity [1,2].  
Vitrectomy surgery is a proven and successful treatment for the complications of PDR where the 
surgical aims of treatment include removing vitreous haemorrhage and relieving vitreoretinal 
traction [3]. However, ERM is observed postoperatively after diabetic vitrectomy in 20–50% of cases, 
is associated with macular thickening, can affect visual outcome and has been reported to require 
revision surgery in 7–22% of cases [4–8]. The exact cause of this is uncertain although surgical and 
proteomic risk factors have been described [9,10]. ILM peeling has been proposed as an effective 
strategy to reduce the occurrence of significant ERM after surgery [11,12] but its use has been 
questioned because of its potential to cause harm [13]. We carried out a prospective study to assess 
the effect of ILM cleaning, without ILM peeling, using a flexible nitinol loop on the occurrence of ERM 
after surgery for PDR. Vitreous proteomic assays were carried out on a range of relevant proteins in 
all cases and peeled ILM was examined by transmission electron microscopy after ILM cleaning in a 
subset of cases.   
Materials and Methods 
Data from consecutive patients undergoing vitrectomy for PDR by one surgeon over a 42-month 
period from 2015 to 2019 was retrospectively analysed. The cohort was divided into two cohorts 
within recruitment occurring in both cohorts over 21 months. In the first cohort, which in henceforth 
referred to as the control cohort, the ILM was not cleaned, and in the second cohort it was cleaned 
with a Finesse flex loop (Alcon Grieshaber, Schaffhausen, Switzerland), otherwise surgery was 
identical.  
Indications for surgery included vitreous haemorrhage, tractional retinal detachment with and 
without a rhegmatogenous component. Patients were excluded if there had been previous 
vitrectomy, there was a prior history of diabetic macular oedema (DMO) requiring treatment with 












   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   





























tamponade was required, there was less than 3 months follow up or postoperative spectral domain 
optical coherence tomography (SDOCT) was not performed 3–4 months postoperatively.  
All surgeries were carried out using the Alcon Constellation 25g Ultravit system (Alcon, Fort Worth, 
Texas, USA) with wide angle viewing using a standardised technique. After core vitrectomy, 
delamination and removal of all posterior hyaloid face and fibrovascular membranes was carried out. 
This was done primarily with the vitreous cutter alone, and intravitreal scissors were used only if 
necessary, as previously described [14,15].  Careful inspection to detect the presence of vitreoschisis 
was carried out and staining of residual vitreous gel using diluted triamcinolone (TMC) was used in all 
cases. Any vitreous remnants and epiretinal membrane detected was peeled using the vitreous 
cutter and forceps as necessary.  
In a second cohort of patients, after staining with TMC, and after peeling of membranes as above, a 
Finesse flex loop was used to gently brush the retina, to remove any residual epiretinal tissue 
present, concentrating on the macula area within the vascular arcades. Particular care was taken to 
brush all areas extending for a disc diameter in radius around the foveal centre in a systematic way 
using radial and concentric brush directions, dictated by surgical ease. The procedure was performed 
regardless of the presence of discernible vitreous remnants identified by TMC, however the presence 
of patches of discernible vitreous remnants with strands or sheets of membrane after TMC 
application was recorded (see supplementary video). 
Endolaser retinal photocoagulation was carried out to complete any deficiencies in previous laser. 
Retinal breaks were treated with argon laser retinopexy. Sulphur hexafluoride gas or air were used as 
postoperative tamponade where needed. Preoperative anti-VEGF therapy was used in selected 
patients relating to the activity and extent of the neovascularization. Combined phacovitrectomy was 
carried out in cases with visually significant cataract obscuring the operative view.  
The primary outcome was the presence and severity of ERM on SDOCT at 3–4 months 
postoperatively. Patients underwent SDOCT (30 by 30° horizontal grid protocol with 60-micron line 
spacing) using a Spectralis HRA®+ SDOCT (Heidelberg Engineering, Heidelberg, Germany). The 
SDOCTs were graded by two independent observers masked to the intervention group for the 
presence of ERM, which was defined as a hyper-reflective inner retinal band. The presence of any 
foveal (within central 1mm2) and eccentric (outside central 1mm2 but within a standard 6mm Early 
Treatment Diabetic Retinopathy Study (ETDRS) circle) ERM was recorded and graded as absent (score 
0), present (score 1), or present and associated with retinal plication and/or peg-like attachments 
(score 2)  (as shown in Fig. 1) and making a total maximum score of 4, as reported previously [16]. 












   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   





























and macular volume were recorded, as was the presence of intraretinal cysts. ERM was designated as 
clinically significant if the following criteria were met: 1) ERM involving the foveal centre associated 
with a change in foveal architecture and plication. 2) Eccentric ERM if associated with retinal 
plication and in continuity with an area of central retinal thickening. 
A variety of pre-, intra- and postoperative characteristics of the patients were recorded, including 
age, gender, type and duration of diabetes and glycosylated haemoglobin (HbA1c) level at the time 
of vitrectomy. The amount of preoperative panretinal photocoagulation (PRP) was graded as equal 
to, or more than, ETDRS full scatter, less than standard ETDRS full scatter or no preoperative PRP 
[17]. The extent of any retinal haemorrhage was recorded as more, less or the same as the standard 
2a photograph used in the ETDRS study and the presence of any preretinal haemorrhage recorded 
[18] and graded as absent, extramacular or premacular. The extent of the vitreoretinal adhesion 
areas was estimated based on disc areas. The position of neovascularisation was recorded as none, 
disc attachment only, posterior pole attachment only or 1–4 quadrants of anterior vitreoretinal 
attachment.  Tractional retinal detachment was recorded as absent, eccentric to macular or macular 
involving. The number of applications of intraoperative laser was recorded. Patients were followed 
up at approximately 3, 6 and 12months postoperatively as per routine care. The number, timing and 
indications for repeat surgery were recorded. Best corrected visual acuity (BCVA) using an ETDRS 
letter chart was recorded at baseline and 3, 6 and 12 months postoperatively, and converted to 
logMAR for analysis. LogMAR values corresponding to count fingers (CF), hand movements (HM), 
perception of light (PL) were substituted with 1.98, 2.28 and 2.70 respectively.  
Proteomics 
In all patients, a sample of undiluted vitreous (0.5–1.0ml) was aspirated with high cut rate into a 2ml 
syringe prior to initiation of full vitrectomy, and then frozen at -80°C. A range of cytokines [10,19] 
and growth factors based on previous work (namely vascular endothelial growth factor (VEGF) A, 
placental growth factor, connective tissue growth factor, monocyte chemoattractant protein 1 (MCP-
1), interleukin 6 (IL-6), interleukin 8 (IL-8), angiopoietin 2, intercellular adhesion molecule 1, matrix 












   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   





























customisable array-based multiplex immunoassay (Human Quantibody array, RayBiotech, Norcross, 
GA, USA) as previously described [19].   
Electron Microscopy 
After completion of recruitment to the main cohort, in four separate patients undergoing vitrectomy 
for PDR, and after ILM cleaning with the Finesse flex loop as per our protocol described above, the 
ILM was peeled and then retrieved for transmission electron microscopy.  
Samples were fixed in 2% glutaraldehyde in 0.1M sodium cacodylate buffer and processed as 
previously described [20]. Detailed examination of the tissue was performed to determine the 
occurrence of any cellular debris on the vitreous surface of the ILM, and any detectable evidence of 
loop related surface marks such as grooving, or ILM disruption. The extent of any vitreous side 
epiretinal membrane was graded in extent as previously described [20].  
Informed consent for the collection of the vitreous and ILM specimens was obtained from the 
subjects after explanation of the nature of the study. These were carried out in accordance with the 
ethical standards of an institutional research committee (National Health Service South East Coast– 
Surrey Research Ethics Committee – reference 12/LO/0130) and with the 1964 Declaration of 
Helsinki and its later amendments. Use of the retrospectively collected clinical data was classed as 
service evaluation under UK guidelines and as such did not require separate ethical review.  
Statistical analysis  
Descriptive and statistical analysis was performed using SPSS version 25. Patients demographic 
characteristics, pre- and post-operative variables are presented in terms of mean, standard deviation 
and range, median, interquartile range or percentage as appropriate. Two-sample unpaired t-tests 
were used to compare continuous variables or the Mann-Whitney test as appropriate. Associations 
between non-continuous variables were analysed using the chi-square test and Fisher’s exact 
probability. Analysis of covariance was used to compare the improvement in vision postoperatively 
at 3-months between the two groups taking into account the preoperative vision as a covariate.   
Logistic regression was performed to assess factors associated with an ERM score of ≥1 












   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   





























being used to retain factors in the model. Statistical significance was considered with a p-value of 
0.05 or less. 
Results 
During the study period 157 primary vitrectomies for the complication of PDR were carried out. 
Silicone oil was used in 7 cases, SDOCT were unavailable for 13 eyes (9 in the control group and 4 in 
the ILM clean group), 21 cases had a prior history of treatment of DMO and 10 eyes were fellow 
eyes. 106 eyes of 106 patients were thus studied, with 50 in the control group and 56 in the ILM 
clean group. The mean age was 52 years (standard deviation 15, range 22 to 82) and 55 (52%) were 
male. The groups were well matched by their clinical features at baseline and as observed during 
surgery (Table 1) and vitreous protein levels (Table 2). All but two patients were white British in 
ethnicity. Follow up was completed in 44/50 (88%) and 38/50 (76%) of the control group and 49/56 
(86%) and 44/56 (79%) in the ILM clean group at 6 and 12 months respectively. 
In the ILM clean group there were patches of discernible vitreous remnants present as manifest by 
TMC staining during surgery in 17 of the 56 (30%) eyes. During the ILM cleaning, an unintentional ILM 
tear was created in 2 eyes, both at approximately 1500 microns from the foveal centre. In these 
cases, the torn ILM was locally removed only without peeling the ILM at the fovea.   
The kappa coefficient for interrater reliability in grading ERM presence on SDOCT was 0.80 (95% 
confidence intervals: 0.66-0.94). There was a significant reduction in the severity of the foveal, 
extrafoveal and clinically significant ERM between the ILM clean and control groups. Similarly, the 
mean CMT and macular volume was reduced in the ILM clean group. There was a significant 
difference in postoperative visual acuity (VA) between the two groups at 3 months (mean logMAR 
0.35 vs. 0.50, p=0.02) (Table 3). When the preoperative VA was included as a covariate the significant 
difference in postoperative vision persisted (p=0.008). The significant difference in postoperative VA 
persisted at 6 months (mean logMAR 0.33 (SD 0.27) vs. 0.46 (SD 0.40), p=0.05) but was non-
significant at 12 months (mean logMAR 0.34 (SD 0.29) vs. 0.43 (SD 0.38), p=0.17).   
There was a reduction in ERM in both patients with vitreous haemorrhage and macular tractional 
retinal detachment, but the effect was only significant in the vitreous haemorrhage group. There was 
no reduction in the occurrence of ERM in the 5 patients with combined tractional rhegmatogenous 
retinal detachment (CTRD) who all had ERM postoperatively (Table 4).  
By the end of 12 months, follow up revision surgery had been required in 7 of the control patients – 5 
for tractional ERM and 2 for postoperative vitreous cavity haemorrhage (POVCH). In the ILM clean 












   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   





























patients were treated with postoperative anti-VEGFs and 3 Iluvien® for DMO. In the ILM clean group, 
3 patients had postoperative anti-VEGFs and 1 Iluvien® for DMO. In both groups, 8 patients 
underwent cataract surgery in the first 12 months following initial vitrectomy (p=0.806).  
Prediction of ERM by baseline features  
Using the overall study population (n=106), 64 (60%) of these patients had at least some ERM 
identified either eccentrically or foveally (defined as a total score of 1 or more out of a maximum of 
4) in the initial 3 months. The features identified by logistic regression as being predictive of ERM 
with a score ≥1 was the control group vs. ILM clean group (odds ratio 3.652 (1.476–9.036), p=0.005), 
number of intraoperative laser applications (odds ratio 0.999 (0.998–1.000), p=0.019) and the 
indication of vitrectomy being a CTRD (odds ratio 3.552 (1.208-10.440), p=0.021).  
Transmission electron microscopy 
In the ILM specimens examined by electron microscopy after ILM cleaning, the ILM surface was 
generally devoid of vitreous side epiretinal membrane, but occasional foci of cells and collagen were 
seen. We found no signs of ILM disruption but did find occasional and rare areas of focal thinning 
which may have been related to the ILM cleaning (as per Fig. 2). 
Discussion 
We found a significant reduction in ERM 3 months after vitrectomy for the complications of PDR in 
the patients who underwent ILM cleaning using the Finesse flex loop. The groups were well matched 
both by clinical features and vitreous protein levels. The reduction in ERM was associated with a 
reduction in retinal thickness compared to the comparator cohort without ILM cleaning, with a 
concomitant significant improvement in VA at 3 months. This difference was non-significant by 12 
months but there was a significant reduction in the requirement for revision vitrectomy in the ILM 
cleaning group. 
The use of TMC to detect residual vitreous attachment in vitrectomy for PDR has been described 
previously [21–23], but we are not aware of a study systematically examining the effect of ILM 
cleaning with a membrane scraping device in patients with PDR. Vitreoschisis and residual vitreous 
adhesion to the ILM surface are well known features of PDR and its associated vitreopathy [1,24–26]. 
Removal of this material can improve surgical results by reducing rebleeding and recurrent traction, 
and the particulate staining achieved by dilute TMC can aid in its identification.  It can however be 
difficult to peel conventionally being tenuous with a tendency to shred with forceps. We chose to use 
the Alcon Grieshaber Finesse flex loop. This is a flexible nitinol loop that in its fully extended position 












   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   





























a series of fine 15micron high tines which can be used to remove the remaining layer of posterior 
cortical vitreous. The tines are triangular shaped and approximately half the height of diamonds on a 
DDMS. Similarly, the loop has approximately half the rigidity of a DDMS reducing the chances of ILM 
trauma, abrasion and unintentional tearing, which only occurred in 2 cases. Interestingly examination 
of the 4 ILM specimens we studied after ILM peeling showed very few signs of inner surface trauma 
or scratches, as has been observed with the DDMS [27,28]. Other authors have used alternative 
instruments to remove vitreous remnants including polyvinyl alcohol sponges in the case of 
rhegmatogenous retinal detachments, which the authors referred to as vitreous wiping [29]. It is 
likely both instruments have the same effect.  We cleaned the ILM in a systematic way even when 
there was no discernible adherent vitreous on the fovea as an adherent layer of epiretinal tissue has 
been shown to be highly prevalent in diabetic eyes with advanced retinopathy [30]. We found that in 
30% of eyes there were macroscopic patches of vitreous remnants identified by TMC at the fovea. 
The presence of ERM after surgery for PDR has been widely reported with its prevalence ranging 
from 20–53% [31–33] relating to case mix and the methods of detection. We found that over 70% of 
our initial control group had some evidence of ERM on SDOCT at 3 months after surgery, although 
this was only thought to be of clinical significance in 20%. Revision surgery was carried out in 5 (10%) 
of these cases, although it has been reported to be a common cause for revision surgery with or 
without associated retinal detachment [8] in some series. Risk factors for the occurrence of 
significant ERM after surgery have been reported as including the activity of the retinopathy, the 
extent of fibrovascular proliferation, the occurrence of postoperative vitreous cavity haemorrhage 
and residual fibrovascular stumps after surgery [9]. It has been noted that IL-6, IL-8 and MCP-1 are 
upregulated in vitreous samples with ERM recurrence undergoing revision surgery relative to the 
original surgery [10]. It has been postulated that its occurrence is related to the pathology of diabetic 
vitreopathy with residual epiretinal tissue acting as both a source and scaffold for recurrent ERM, 
with inflammatory and pro fibrotic mediators associated with both the PDR and the surgery itself 
stimulating proliferation and contracture of epiretinal remnants [9]. Pre-existing and surgically 
induced retinal holes may also contribute to the process by adding to the complexity of dissection 
and leaving residual epiretinal membranes, tissue trauma from hole creation and laser, and retinal 
pigment epithelium cell migration. In keeping with this, we found that the amount of intraoperative 
laser applications and the presence of a CTRD were predictive for the risk of clinically significant ERM 
occurring after surgery. Indeed, of the 5 eyes with CTRDs included in the total cohort, 4 developed 
clinically relevant ERMs after surgery, including one in the ILM clean group, although this case did not 
undergo revision surgery as it was felt to be too mild to warrant repeat intervention. We measured 












   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   





























PDR in previous studies at the time of vitrectomy surgery [19]. We did not find any of the proteins 
were predictive of postoperative ERM. Importantly however there was no significant difference in 
the levels between the two cohorts reinforcing their matching.  
Other authors have proposed ILM peeling as a technique to reduce ERM formation in vitrectomy for 
PDR [11,12] with a reduction in the occurrence of ERM from 38–49% to 0–21%. There have been 
reports of reduced vision after ILM peeling in advanced diabetic retinopathy perhaps relating to the 
greater adherence of ILM to its underlying Müller cell endplates with greater resultant trauma in 
diabetic eyes [13,34,35]. Despite reducing macular thickness, ILM peeling did not improve VA 
significantly at 3 months in either of the two cited studies and also has not been shown to improve 
visual results in patients undergoing vitrectomy for diabetic macular oedema [36]. We therefore 
wished to assess whether ILM cleaning could give comparable results to ILM peeling without the 
associated risks and perhaps improved vision. ILM cleaning significantly reduced the occurrence and 
severity of ERM, including clinically significant ERM from 10 (20%) cases to 2 (4%) and no cases 
required revision surgery for ERM in the ILM clean cohort, compared to 5 in the control group. The 
central macular thickness was reduced as was the case after ILM peeling, and VA was improved at 3 
months but not after 12 months when revision surgery had been completed and several patients had 
undergone treatment for macular oedema. The apparent improvement by 12 months in VA in the 
control group (3-month mean: 0.50 logMAR; 12-month mean: 0.43 logMAR) compared to the 
stability of the ILM-Clean group (3-month mean: 0.35 logMAR; 12-month mean: 0.34 logMAR) was 
due to the increased proportion of control group patients treated with revision surgery (14% vs. 2%), 
intravitreal medication (12% vs. 7%) or cataract surgery (16% vs. 14%).  
ILM cleaning did not eliminate all ERM but there were only 4 (7%) cases with ERM involving the 
central 1mm in the ILM clean group compared to 9 (18%) in the control group. Similarly, 
Michalewska et al found that 21% of patients that had ILM peeling had ERM outside the area of the 
ILM peel [12]. We also observed that on the four ILMs examined with TCM after cleaning, there were 
small remnants of ERM still persistent albeit sparse. It would appear that it is difficult to completely 
clean the ILM of all epiretinal tissue. It is also worth noting that postoperative ERM is more common 
in CTRD cases perhaps relating to cellular migration through the retinal breaks. Similarly, the 
reduction in ERM in cases with macular tractional rhegmatogenous retinal detachments was non-
significant perhaps relating to greater Müller cell activation. 
The study has several limitations. It was not randomised but the groups were well matched for 
baseline clinical features including vitreous attachment, extent of intraoperative laser and vitreous 












   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   





























as the majority of the patients had vitreous haemorrhage at baseline so could not exclude a 
difference in macular thickening at baseline between the groups. In should be noted however that 
we excluded patients with known pre-existing maculopathy to reduce this risk. We excluded patients 
requiring silicone oil insertion and so cannot extrapolate our results to them. We only recorded ERM 
at one-time point postoperatively and results may have differed at other time points. ERM after 
vitrectomy has been shown to vary with the time postoperatively [32], but all the patients who 
required vitrectomy for ERM in the 12 months follow up had clinically significant ERM at the 3-month 
time point. Late ERM formation significant enough to require vitrectomy would appear to be rare. 
The population studied was overwhelmingly white Caucasian and results may differ in other racial 
groups. We did not have details of postoperative glucose control but preoperatively there was no 
significant difference in glycosylated haemoglobin preoperatively between the groups.  
Conclusion 
In conclusion, we report a significant reduction in the prevalence of ERM after vitrectomy for PDR by 
using a technique of ILM cleaning with a flexible nitinol loop. Repeat surgery for tractional 
maculopathy within 12 months postoperatively was reduced by means of the technique, and there 
was a significant improvement in postoperative VA at 3 and 6 months postoperatively. Patients with 
CTRDs had a higher incidence of postoperative ERM which was not prevented by ILM cleaning 
suggesting that other techniques should be considered in this group of patients in particular. Further 
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Fig. 1. Grading of ERM on SDOCTs at 3 months postoperatively. Panel ‘a’ illustrates an ERM with 
plication and involvement of the central fovea. Panel ‘b’ shows a linear ERM with foveal 
involvement. Note in this image an ETDRS grid has been overlaid on the infrared image to allow 
accurate detection of the extent of the ERM. Panel ‘c’ shows an eye with no discernible ERM. 
Fig. 2. Transmission electron microscopy images of peeled ILM after ILM cleaning. Panel ‘a’ shows a 
segment of ILM with clean and smooth vitreous side of the ILM and irregular retinal side. Panel ‘b’ is 
a higher power view of ‘a’. There were infrequent areas of ILM with focal irregularities in the 
vitreous side (arrows) (Panel ‘c’). There were also occasional areas of cellular remnants (arrow) 














   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   






































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   






































   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   



























Table 1 Comparison of demographic and clinical features between patients who underwent 
additional inner limiting membrane cleaning and those that did not following vitrectomy for 
Proliferative Diabetic Retinopathy in valid study eyes (n=106) 
  





Age, years   
mean, SD, (min–max) 
54.3,15.4 (27–81) 51.6,14.4 (22–82) 0.37 
Gender  
n, (%) 
Male – 29 (52%) 
 
Male – 26 (52%) 
 
0.98 
Indication for vitrectomy:  
VH, MT, CTRD 
n, (%) 
VH – 40 (71%) 
MT – 14 (25%) 
CTRD – 2 (4%) 
VH – 39 (78%) 
MT – 8 (16%) 
CTRD – 3 (6%) 
0.47 
Type Diabetes (Type1, Type 2) n, (%) Type1 – 32 (57%) Type1 – 19 (38%) 0.07 
Duration Diabetes, Years  
mean, SD, (min–max) 
23.3, 10.7 (8–51) 20.5, 9.0 (4–51) 0.14 
HbA1c (mmol/l)  
mean, SD, (min–max) 
74.6, 13.9 (42–115) 79.8, 20.6 (37–140) 0.13 
Preoperative visual acuity, logMAR  
mean, SD, (min–max) 
1.43, 0.53 (0.3–2.3) 1.37, 0.54 (0.2–2.0) 0.58 
 
Preoperative PRP extent (None, less than 
standard ETDRS scatter (1), equal to or 
more than standard ETDRS scatter (2))  
n, (%) 
None – 3 (5%) 
1 – 6 (10%) 
2 – 47(85%) 
 
None – 2 (4%) 
1 – 7 (14%) 
2 – 41(82%) 
 
0.92 
Extent of retinal haem (less than ETDRS 
standard photo 2a (1), equal to 2a (2) or 
greater than 2a (3))  
n, (%) 
1 – 1 (2%) 
2 – 28 (50%) 
3 – 27 (48%) 
 
1 – 4 (8%) 
2 – 14 (28%) 
3 – 32 (64%) 
 
0.84 
Pre retinal haemorrhage (None, 
extrafoveal (1), foveal involving (2))  
n, (%) 
None – 37 (66%) 
1 – 16 (29%) 
2 – 3(5%) 
None – 38 (76%) 
1 – 6 (12%) 
2 – 6 (12%) 
0.07 
Presence of any traction retinal 
detachment (None, extra–macular (1) and 
macular involving (2))  
n, (%) 
None – 23 (41%) 
1 – 24 (43%) 
2 – 9 (16%) 
 
None – 27 (54%) 
1 – 12 (24%) 
2 – 11 (22%) 
 
0.39 
Location of vitreoretinal adhesion (None, 
disc only (1), posterior retinal only (2), 
posterior and 1 quadrant anteriorly (3), 
posterior and 2 or more anterior quadrants 
(4))  
n, (%)  
None – 2 (4%) 
1 – 5 (9%) 
2 – 43 (59%) 
3 – 10 (18%) 
4 – 6 (11%) 
None – 3 (6%) 
1 – 4 (8%) 
2 – 32 (64%) 
3 – 5 (10%) 
4 – 6 (12%) 
0.82 
Total disc areas of vitreoretinal attachment  
median, interquartile range, maximum 
6, 5, 20 4, 5.5, 25 0.27 
Tamponade used (None vs gas) 
n, (%) 












   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   



























Baseline lens status 
n, (%) 
Phakic – 50 (89%) Phakic – 45 (90%) 0.90 
Combined phacovitrectomy performed  
n, (%) 
Yes – 6 (15%) Yes – 8 (16%) 0.99 
Preoperative anti–VEGF given   
n, (%) 
Yes – 28 (51%) Yes – 18 (36%) 0.17 
Intraoperative laser applications 








ILM: Inner Limiting Membrane, SD: Standard Deviation, VH: Vitreous Haemorrhage, MT: Macular 
Traction, CTRD: Combined Tractional and Rhegmatogenous Retinal Detachment, PRP: Panretinal 
photocoagulation, ETDRS: Early Treatment Diabetic Retinopathy Study, VEGF: Vascular endothelial 














   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   




























Table 2 Comparison of cytokine and growth factor levels measured in undiluted vitreous samples 
taken prior to vitrectomy for Proliferative Diabetic Retinopathy in valid study eyes (n=106) between 




ILM clean Group (n=56) Control Group (n=50) p 
MCP-1 (mean, SD) 3619.3, 727.5 3922.0, 819.5 0.11 
IL-6 (mean, SD) 921.7, 994.6 1628.4, 2064.6 0.07 
IL-8 (mean, SD) 1507.5, 1254.4 1406.8, 1246.9 0.73 
VEGF-A (mean, SD) 13957.2, 22973.0 15228.0, 26809.3 0.51 
PLGF (mean, SD) 359.9, 628.1 610.6, 1182.1 0.27 
CTGF (mean, SD) 529401.2, 433274.3 448099.5, 377463.3 0.38 
ICAM-1 (mean, SD) 183.8, 69.7 144.4, 61.5 0.89 
MMP-2 (mean, SD) 52.0, 96.2 31.4, 50.1 0.22 
MMP-9 (mean, SD) 137.7, 187.7 107.6, 201.5 0.49 
TNFα (mean, SD) 21.4, 19.1 26.4, 25.9 0.36 
Ang-2 (mean, SD) 18787.7, 29171.8 12658.4, 18899.2 0.27 
 
ILM: Inner Limiting Membrane, MCP-1: Monocyte chemoattractant protein 1, SD: Standard 
Deviation, IL-6: Interleukin 6, IL-8: Interleukin 8, VEGF-A: Vascular endothelial growth factor A, PLGF: 
Placental growth factor, CTGF: Connective tissue growth factor, ICAM-1: Intercellular adhesion 
molecule 1, MMP-2: Matrix metalloproteinase 2, MMP-9: Matrix metalloproteinase 9, TNFα: Tissue 












   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   




























Table 3 Comparison of postoperative outcomes following vitrectomy for Proliferative Diabetic 
Retinopathy at 3 months postoperatively. 
 
Postoperative Outcome ILM clean GROUP 
(n=56) 
Control Group  
(n=50) 
p 
Foveal ERM (0-2) (n, %)   None – 52 (93%) 
1 – 4 (7%) 
2 – 0 (0%) 
None – 39 (78%) 
1 – 9 (18%) 
2 – 2 (4%) 
0.03 
Eccentric ERM (0-2) (n, %)   0 – 32 (57%) 
1 – 21 (38%) 
2 – 3 (5%) 
0 – 12 (24%) 
1 – 24 (48%) 
2 – 14 (28%) 
<0.001 
Clinically significant ERM (present) 
(n, %)  
2 (4%) 10 (20%) 0.01 
Postoperative visual acuity (logMAR) 
(mean, SD, min-max)  
0.35, 0.23 (0.1-1.8) 0.50, 0.40 (0.1-1.3) 0.02 
CMT (microns) 
(mean, SD, min-max) 
293, 51 (195-420) 335, 92 (198-593) 0.002 
Macular Volume (mm3) 
(mean, SD, min-max) 
8.0, 1.1 (5.3-10.3) 8.1, 1.3 (5.4-11.2) 0.07 
CMT >400 microns (present) n, (%) 3 (5%) 10 (20%) 0.04 
Macular cysts (present) n, (%) 7 (13%) 14 (25%) 0.21 
 
















   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   



























Table 4 Comparison of epiretinal membrane presence on 3-month imaging broken down by primary 
indication for vitrectomy. 
 
 Presence of any ERM on SDOCT (i.e. with score ≥1) 
Primary indication for 
vitrectomy 
ILM clean GROUP (n=56) Control Group (n=50) p 
Vitreous haemorrhage  
n/N (%)  
20/40 (50%) 30/39 (77%) 0.002 
Macular TRD 
n/N (%) 
3/14 (21%) 6/8 (75%) 0.22 
CTRD 
n/N (%) 
2/2 (100%) 3/3 (100%) 1 
 
 
ERM: Epiretinal Membrane, SDOCT: Spectral Domain Optical Coherence Tomography, ILM: Inner Limiting 














   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   




























Supplementary Table 1 Comparison of postoperative outcomes following vitrectomy due to vitreous 
haemorrhage secondary to Proliferative Diabetic Retinopathy at 3 months postoperatively. 
 
Postoperative Outcome ILM clean GROUP 
(n=40) 
Control Group  
(n=39) 
p 
Foveal ERM (0-2) (n, %)   None – 38 (95%) 
1 – 2 (5%) 
2 – 0 (0%) 
None – 32 (82%) 
1 – 7 (18%) 
2 – 0 (0%) 
0.09 
Eccentric ERM (0-2) (n, %)   0 – 21 (53%) 
1 – 18 (45%) 
2 – 1 (2%) 
0 – 10 (26%) 
1 – 21 (54%) 
2 – 8 (20%) 
0.008 
Clinically significant ERM (present) 
(n, %)  
0 (0%) 5 (13%) 0.03 
Postoperative visual acuity (logMAR) 
(mean, SD, min-max)  
0.34, 0.23 (0.1-1.3) 0.45, 0.30 (0.1-1.3) 0.07 
CMT (microns) 
(mean, SD, min-max) 
294, 51 (223-420) 332, 86 (198-593) 0.02 
Macular Volume (mm3) 
(mean, SD, min-max) 
8.0, 1.3 (5.3-10.3) 8.4, 1.2 (5.4-11.2) 0.19 
CMT >400 microns (present) n, (%) 3 (8%) 5 (13%) 0.48 
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